OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
Ikhwan Rinaldi, Samuel Pratama, Lowilius Wiyono, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Ikhwan Rinaldi, Samuel Pratama, Lowilius Wiyono, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Showing 16 citing articles:
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 52
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 52
Oral anti‐viral therapy for early COVID ‐19 infection in patients with haematological malignancies: A multicentre prospective cohort
Carla Minoia, Lucia Diella, Tommasina Perrone, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 5, pp. 928-936
Open Access | Times Cited: 7
Carla Minoia, Lucia Diella, Tommasina Perrone, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 5, pp. 928-936
Open Access | Times Cited: 7
Smartphone sensors for evaluating COVID-19 fear in patients with cancer: a prospective study
Gabrielė Kasputytė, Gabrielė Jenciūtė, Nerijus Šakinis, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Gabrielė Kasputytė, Gabrielė Jenciūtė, Nerijus Šakinis, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
Tzong‐Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 403-413
Open Access | Times Cited: 2
Tzong‐Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 403-413
Open Access | Times Cited: 2
Management of vaccinations in patients with non‐Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Unbiased immunome characterisation correlates with COVID-19 mRNA vaccine failure in immunocompromised adults
Juan H-Vázquez, Paloma Cal-Sabater, Elisa Arribas‐Rodríguez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Juan H-Vázquez, Paloma Cal-Sabater, Elisa Arribas‐Rodríguez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies
Tommaso Francesco Aiello, Olivier Peyrony, Mariana Chumbita, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Tommaso Francesco Aiello, Olivier Peyrony, Mariana Chumbita, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
COVID-19 vaccination outcomes in patients with a solid malignancy: Insights from extensive real-world data and propensity score matched analyses
George Dimitrov, Krassimir Kalinov, Trifon Valkov
American Journal of Infection Control (2023) Vol. 52, Iss. 6, pp. 678-682
Open Access | Times Cited: 2
George Dimitrov, Krassimir Kalinov, Trifon Valkov
American Journal of Infection Control (2023) Vol. 52, Iss. 6, pp. 678-682
Open Access | Times Cited: 2
COVID-19-related burnout reduces COVID-19 vaccination intention in cardiac patients: a cross-sectional study in Greece
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies
Shmuel Shoham, Daniele Focosi, Massimo Franchini, et al.
Expert Review of Hematology (2024)
Closed Access
Shmuel Shoham, Daniele Focosi, Massimo Franchini, et al.
Expert Review of Hematology (2024)
Closed Access
Unbiased spectral cytometry immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies
Juan H-Vázquez, Paloma Cal-Sabater, Elisa Arribas‐Rodríguez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Juan H-Vázquez, Paloma Cal-Sabater, Elisa Arribas‐Rodríguez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
Ana Căruntu, Constantin Căruntu, Cristian Scheau
Medicina (2022) Vol. 58, Iss. 11, pp. 1576-1576
Open Access
Ana Căruntu, Constantin Căruntu, Cristian Scheau
Medicina (2022) Vol. 58, Iss. 11, pp. 1576-1576
Open Access
Real-world data on bio-clinical follow-up after vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in 216 patients with hematological malignancies
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Research Square (Research Square) (2022)
Open Access
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Research Square (Research Square) (2022)
Open Access
